Defence Therapeutics

Defence Therapeutics is a publicly traded Canadian biotechnology company focused on making cancer treatments more effective and safer. Its Accum® precision drug-delivery platform is designed to improve the potency and intracellular delivery of antibody-drug conjugates and other complex biologics at lower doses, potentially reducing toxicity and side effects. The company develops therapies internally and with pharmaceutical and biotechnology partners, advancing precision oncology and patient access.